药物对比
Semaglutide vs Gliquidone
Semaglutide与Gliquidone治疗2型糖尿病对比：GLP-1受体激动剂与磺脲类。比较疗效、减重、低血糖风险、心血管获益和安全性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting add-on or alternative oral/injectable therapy for type 2 diabetes after metformin, balancing modern GLP-1 benefits against traditional sulfonylurea options.
结论
Semaglutide often outperforms Gliquidone in efficacy, weight, and cardiovascular outcomes, though Gliquidone remains a lower-cost oral alternative in selected patients.
全部药物对比